Position in NTRA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$276,424,321
+$97,768,855 QoQ
Shares Held
1,018,325
+14.0% QoQ
Ownership
0.706%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#28
of 844 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Clearbridge Investments, LLC holds $1,898,720,564 across 10 Diagnostics & Research names. NTRA ranks #2 (14.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
1,691,069 | $847,834,353 | |
| 2 | NTRA |
Natera, Inc.
This page
|
1,018,325 | $276,424,321 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
379,502 | $199,785,032 | |
| 4 | CRL |
Charles River Laboratories International, Inc.
|
781,276 | $177,185,584 | |
| 5 | MEDP |
Medpace Holdings, Inc.
|
226,104 | $119,742,417 | |
| 6 | RDNT |
RadNet, Inc.
|
1,546,652 | $95,382,028 | |
| 7 | WAT |
Waters Corp /De/
|
170,887 | $64,089,460 | |
| 8 | DHR |
Danaher Corp /De/
|
228,767 | $43,575,538 |
All Filings in NTRA
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $276,424,321 | 1,018,325 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $178,655,466 | 893,322 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $181,004,238 | 790,101 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $129,004,577 | 801,420 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $57,818,363 | 342,242 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $44,962,582 | 317,959 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $46,602,728 | 294,395 | Shares | Sole | 2025-02-12 | |
| No filing history on record for this holder in this stock. | ||||||